Reliv' International, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RELV research report →
Price Chart
About the company
Reliv' International, Inc. develops, manufactures, and markets proprietary nutritional supplements. The company offers joint health, protein, gluten free, targeted solutions, blood sugar support, cellular health, cognitive functions and focus, cholesterol support, kid’s nutrition, digestive health, discomfort, energy, aging, heart health, hemp, and immune support products.
- CEO
- Ryan A. Montgomery
- IPO
- 2016
- Employees
- 44
- HQ
- Chesterfield, MO, US
Get TickerSpark's AI analysis on RELV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.20M
- P/E
- -2.06
- PEG
- -0.03
- P/S
- 0.16
- P/B
- 0.35
- EV/EBITDA
- -3.03
- Div Yield
- 0.00%
- Gross Margin
- 45.18%
- Op Margin
- -5.58%
- Net Margin
- -4.93%
- ROE
- -15.66%
- ROIC
- -13.20%
Latest fiscal year · YoY change
- Revenue
- $20.55M-2.1%
- Gross Profit
- $8.99M-3.0%
- Op Income
- $-1,674,789
- Net Income
- $-1,551,235+19.8%
- EPS
- $-1.43+21.9%
- OCF Growth
- -81.0%
- FCF Growth
- -43.5%
- 52W High
- $3.50
- 52W Low
- $1.70
- 50D MA
- $2.02
- 200D MA
- $2.20
- Beta
- 0.29
- RSI (14)
- 33
- Avg Volume
- 246
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Reliv’s third quarter improved sequentially, but year-over-year sales and earnings still declined as the company cut its dividend to preserve cash and reinvest in the business.· October 29, 2009
- Net sales were $20.9 million, down from $23.9 million a year ago, while net income fell to $324,000 or $0.03 per diluted share from $536,000 or $0.04.
- The quarter showed early signs of stabilization: net sales rose about 4% sequentially from Q2, orders were at their best level in five quarters, and new distributor sign-ups increased 5%.
- Gross margin slipped to 78.7% from 81.3% last year, pressured by lower plant utilization, slightly higher ingredient costs, and revenue mix.
- Management introduced the new Relivables product line and expanded autoship programs, both intended to lift orders and average order size.
- The company reduced its quarterly dividend from $0.05 to $0.02 per share to redirect savings into strengthening the business.
Third-quarter 2009 net sales were $20.9 million, down from $23.9 million in the prior-year quarter. U.S. net sales were $18.3 million versus $20.8 million, and international net sales were $2.6 million versus $3.0 million, a decline of about 14% (or about 5% excluding currency effects). Net income was $324,000, or $0.03 per diluted share, versus $536,000, or $0.04 per diluted share, a year ago. Gross margin was 78.7% versus 81.3% last year, operating margin was 2.2% versus 4.7%, and distributor royalties and commissions were 37.9% of sales versus 39.1%. For the first nine months, net sales were $64.7 million versus $76.1 million, net income was $1.7 million versus $2.6 million, and diluted EPS was $0.13 versus $0.17. Cash from operations for the first nine months was $4.8 million, up about 34%, and cash and cash equivalents were $6.4 million as of September 30, 2009. Long-term debt plus the outstanding line of credit balance totaled approximately $6.4 million. No explicit full-year or next-quarter revenue/EPS guidance was provided; the main forward-looking comments centered on expected growth from Relivables, autoship expansion, and international expansion, plus the dividend cut from $0.05 to $0.02 per share.
CEO Robert Montgomery struck a cautious but somewhat encouraged tone. He said third-quarter performance was down year over year, but highlighted “glimmers of light,” including a 5% increase in new distributors, more orders, and the first sequential sales increase from Q2 to Q3 since 2006. He emphasized Relivables, autoship expansion, the Financial Freedom Tour, and the opening of Indonesia as key initiatives to support growth heading into 2010.
CFO Steve Albright focused on the financial decline versus last year but also pointed to operating and cash-flow discipline. He cited 78.7% gross margin, 37.9% distributor royalties and commissions as a percentage of sales, 38.6% SG&A as a percentage of sales, and 2.2% operating margin; he also noted SG&A was almost $900,000 lower than a year ago. He said net cash from operations for the first nine months was $4.8 million, helped by an more than 18% reduction in inventories, and that cash and cash equivalents were $6.4 million at quarter-end. He also explained that the dividend was cut to save cash and strengthen the business, with the annual dividend reduced to $0.07 from $0.10 per share.
There was no analyst Q&A; the operator stated there were no questions at this time. As a result, the call did not surface additional external concerns or management clarifications beyond the prepared remarks. The main implied concerns were the ongoing sales decline, lower margin, and softer distributor metrics, which management addressed through product launches, autoship expansion, international growth, and cost/cash actions.
The bull case from this call is that the business showed early sequential improvement after a weak stretch: sales rose 4% from Q2, orders hit their best level in five quarters, and new distributor sign-ups grew 5%. Management also pointed to new products, autoship expansion, and Indonesia as initiatives that could lift order frequency and average order size.
The bear case is that the company is still seeing meaningful year-over-year pressure: sales, income, EPS, and gross margin were all down, and master affiliate generation in the U.S. fell about 23%. The dividend cut underscores management’s desire to conserve cash, and the company acknowledged that economic conditions were still hampering performance.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 63.1%
- Shares Outstanding
- 1.75M
- Float Shares
- 1.10M
of shares held by institutions
6 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Ladenburg Thalmann Financial Services Inc. | 14 | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 31, 17 | MERRICK STEPHEN M | other | 0 |
| Dec 28, 17 | MONTGOMERY ROBERT L | buy | 1,220 |
| Dec 19, 17 | MONTGOMERY ROBERT L | buy | 100 |
| Dec 13, 17 | MONTGOMERY ROBERT L | buy | 1,200 |
| Dec 12, 17 | MONTGOMERY ROBERT L | buy | 4,559 |
| Dec 11, 17 | MONTGOMERY ROBERT L | buy | 4,648 |
| Dec 8, 17 | MONTGOMERY ROBERT L | buy | 200 |
| Dec 7, 17 | MONTGOMERY ROBERT L | buy | 8,100 |
| Dec 7, 17 | MONTGOMERY ROBERT L | buy | 8,100 |
| Mar 31, 16 | MONTGOMERY ROBERT L | buy | 2,100 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RELV coverage
Recent articles, reports, and earnings notes.
No research on RELV yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RELV report →Reliv International, Inc. Announces Update to its Reverse Stock Split Transaction and Plan to Delist from NASDAQ and Deregister its Common Stock
prnewswire.com · Dec 4
Reliv International Reports Third-Quarter Financial Results for 2020
prnewswire.com · Nov 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.